Cargando…

Minimising the harm from nicotine use: finding the right regulatory framework

The tobacco problem can be usefully conceptualised as two problems: eliminating the most harmful forms of nicotine use (certainly cigarettes, and probably all smoked tobacco), and minimising the use and/or harms from use of lower-harm, but addictive forms of nicotine. A possible target would be to e...

Descripción completa

Detalles Bibliográficos
Autor principal: Borland, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632982/
https://www.ncbi.nlm.nih.gov/pubmed/23591515
http://dx.doi.org/10.1136/tobaccocontrol-2012-050843
_version_ 1782266921882746880
author Borland, Ron
author_facet Borland, Ron
author_sort Borland, Ron
collection PubMed
description The tobacco problem can be usefully conceptualised as two problems: eliminating the most harmful forms of nicotine use (certainly cigarettes, and probably all smoked tobacco), and minimising the use and/or harms from use of lower-harm, but addictive forms of nicotine. A possible target would be to effectively eliminate use of the most harmful forms of nicotine within the next decade and then turn our focus to a long-term strategy for the low-harm forms. This paper focuses on the administrative framework(s) needed to accomplish these twin tasks. For a phase-out taking a long time and/or for dealing with residually net harmful and addictive products, there are severe limitations to allowing for-profit marketing of tobacco because such an arrangement (the current one in most countries) can markedly slow down progress and because of the difficulty of constraining marketing in ways that minimise undesirable use. A harm reduction model where the marketing is under the control of a non-profit entity (a regulated market) is required to curtail the incredible power of for-profit marketing and to allow tobacco marketing to be done in ways that further the goal of minimising tobacco-related harm. Countries with a nationalised industry can move their industry onto a harm minimisation framework if they have the political will. Countries with a for-profit industry should consider whether the time and effort required to reconstruct the market may, in the longer term, facilitate achieving their policy goals.
format Online
Article
Text
id pubmed-3632982
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36329822013-04-25 Minimising the harm from nicotine use: finding the right regulatory framework Borland, Ron Tob Control Endgame Proposal The tobacco problem can be usefully conceptualised as two problems: eliminating the most harmful forms of nicotine use (certainly cigarettes, and probably all smoked tobacco), and minimising the use and/or harms from use of lower-harm, but addictive forms of nicotine. A possible target would be to effectively eliminate use of the most harmful forms of nicotine within the next decade and then turn our focus to a long-term strategy for the low-harm forms. This paper focuses on the administrative framework(s) needed to accomplish these twin tasks. For a phase-out taking a long time and/or for dealing with residually net harmful and addictive products, there are severe limitations to allowing for-profit marketing of tobacco because such an arrangement (the current one in most countries) can markedly slow down progress and because of the difficulty of constraining marketing in ways that minimise undesirable use. A harm reduction model where the marketing is under the control of a non-profit entity (a regulated market) is required to curtail the incredible power of for-profit marketing and to allow tobacco marketing to be done in ways that further the goal of minimising tobacco-related harm. Countries with a nationalised industry can move their industry onto a harm minimisation framework if they have the political will. Countries with a for-profit industry should consider whether the time and effort required to reconstruct the market may, in the longer term, facilitate achieving their policy goals. BMJ Publishing Group 2013-05 /pmc/articles/PMC3632982/ /pubmed/23591515 http://dx.doi.org/10.1136/tobaccocontrol-2012-050843 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode
spellingShingle Endgame Proposal
Borland, Ron
Minimising the harm from nicotine use: finding the right regulatory framework
title Minimising the harm from nicotine use: finding the right regulatory framework
title_full Minimising the harm from nicotine use: finding the right regulatory framework
title_fullStr Minimising the harm from nicotine use: finding the right regulatory framework
title_full_unstemmed Minimising the harm from nicotine use: finding the right regulatory framework
title_short Minimising the harm from nicotine use: finding the right regulatory framework
title_sort minimising the harm from nicotine use: finding the right regulatory framework
topic Endgame Proposal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632982/
https://www.ncbi.nlm.nih.gov/pubmed/23591515
http://dx.doi.org/10.1136/tobaccocontrol-2012-050843
work_keys_str_mv AT borlandron minimisingtheharmfromnicotineusefindingtherightregulatoryframework